Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000487006 | SCV000565512 | likely pathogenic | not provided | 2014-12-17 | criteria provided, single submitter | clinical testing | A novel D4001G variant that is likely pathogenic was identified in the RYR2 gene. It has not been published as a pathogenic variant, nor has it been reported as a benign polymorphism to our knowledge. The D4001G variant was not observed in approximately 6,000 individuals of European and African American ancestry in an external variant database, indicating it is not a common benign variant in these populations. The D4001G variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Additionally, this substitution occurs at a position that is conserved across species and in silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, missense variantas in nearby residues (K3997E, M4002I) have been reported in the Human Gene Mutation Database (Stenson P. et al., 2014) and D4001G is located in a mutation hot spot" in the RYR2 gene (Medeiros-Domingo A et al., 2009). Therefore, this is a strong candidate for a pathogenic variant, however the possibility that it is a benign variant cannot be excluded." |